WallStSmart

Haoxi Health Technology Limited (HAO)vsNebius Group N.V. (NBIS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nebius Group N.V. generates 3075% more annual revenue ($1.36B vs $42.68M). NBIS leads profitability with a 3.1% profit margin vs -6.5%. HAO earns a higher WallStSmart Score of 49/100 (D+).

HAO

Hold

49

out of 100

Grade: D+

Growth: 8.7Profit: 2.0Value: 5.0Quality: 9.0
Piotroski: 4/9Altman Z: 5.80

NBIS

Hold

43

out of 100

Grade: D

Growth: 8.0Profit: 3.0Value: 7.7Quality: 6.5
Piotroski: 5/9Altman Z: 1.10
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for HAO.

NBISUndervalued (+55.3%)

Margin of Safety

+55.3%

Fair Value

$468.72

Current Price

$223.54

$245.18 discount

UndervaluedFair: $468.72Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HAO5 strengths · Avg: 9.8/10
Price/BookValuation
0.0x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
41.2%10/10

Revenue surging 41.2% year-over-year

EPS GrowthGrowth
172.7%10/10

Earnings expanding 172.7% YoY

Altman Z-ScoreHealth
5.8010/10

Safe zone — low bankruptcy risk

Debt/EquityHealth
0.109/10

Conservative balance sheet, low leverage

NBIS3 strengths · Avg: 9.0/10
Revenue GrowthGrowth
454.0%10/10

Revenue surging 454.0% year-over-year

Market CapQuality
$57.01B9/10

Large-cap with strong market position

PEG RatioValuation
0.538/10

Growing faster than its price suggests

Areas to Watch

HAO4 concerns · Avg: 2.0/10
Market CapQuality
$1.02M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-15.5%2/10

ROE of -15.5% — below average capital efficiency

Free Cash FlowQuality
$-2.27M2/10

Negative free cash flow — burning cash

Profit MarginProfitability
-6.5%1/10

Currently unprofitable

NBIS4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
0.6%3/10

ROE of 0.6% — below average capital efficiency

Profit MarginProfitability
3.1%3/10

3.1% margin — thin

Free Cash FlowQuality
$-3.41B2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : HAO

The strongest argument for HAO centers on Price/Book, Revenue Growth, EPS Growth. Revenue growth of 41.2% demonstrates continued momentum.

Bull Case : NBIS

The strongest argument for NBIS centers on Revenue Growth, Market Cap, PEG Ratio. Revenue growth of 454.0% demonstrates continued momentum. PEG of 0.53 suggests the stock is reasonably priced for its growth.

Bear Case : HAO

The primary concerns for HAO are Market Cap, Return on Equity, Free Cash Flow.

Bear Case : NBIS

The primary concerns for NBIS are EPS Growth, Return on Equity, Profit Margin. Thin 3.1% margins leave little buffer for downturns.

Key Dynamics to Monitor

NBIS carries more volatility with a beta of 1.44 — expect wider price swings.

NBIS is growing revenue faster at 454.0% — sustainability is the question.

HAO generates stronger free cash flow (-2M), providing more financial flexibility.

Monitor ADVERTISING AGENCIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

HAO scores higher overall (49/100 vs 43/100) and 41.2% revenue growth. NBIS offers better value entry with a 55.3% margin of safety. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Haoxi Health Technology Limited

COMMUNICATION SERVICES · ADVERTISING AGENCIES · USA

Haoxi Health Technology Limited Class A Ordinary Shares is a pioneering force in the health technology sector, focused on revolutionizing healthcare through innovative, technology-driven solutions. The company harnesses advanced artificial intelligence and data analytics to enhance diagnostic precision, streamline treatment processes, and improve patient management. With a robust commitment to research and development, Haoxi is well-positioned to tackle emerging healthcare challenges, presenting substantial growth opportunities for institutional investors aiming to leverage advancements in this dynamic and rapidly evolving market.

Nebius Group N.V.

COMMUNICATION SERVICES · INTERNET CONTENT & INFORMATION · USA

Nebius Group N.V. (Ticker: NBIS) is an innovative technology firm that specializes in advanced digital solutions to enhance client engagement and operational efficiency across diverse sectors. By integrating cutting-edge cloud computing, artificial intelligence, and data analytics, Nebius enables businesses to adeptly manage the complexities of today's digital landscape. The company boasts a strong portfolio of intellectual property and strategic partnerships, positioning it favorably to capitalize on significant growth opportunities in the technology-driven marketplace. As such, Nebius presents a compelling investment opportunity for institutional investors seeking to gain exposure to pioneering solutions in the tech sector.

Visit Website →

Want to dig deeper into these stocks?